Provided herein are fusion proteins including at least one binding polypeptide and at least
one unstructured polypeptide. The fusion protein may further include at least one linker …

SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O [C@@ H] 1 [C@@
H](O)[C@ H](O)[C@@ H](CN) O [C@@ H] 1O [C@ H] 1 [C@ H](O)[C@@ H](O [C@@ H] 2 …

Disclosed herein are compositions and methods for reducing the antigenicity of molecules.
The antigenicity of a molecule may be reduced or eliminated by conjugating at least one …

5,362,646 A 5,464,758 A 5,589,362 A 5,650,298 A 5,654,168 A 5,789,156 A 5,814,618 A
5,888,981 A 5,922,927 A 6,004,941 A 6,087,166 A 6,136,954 A 6,242,667 B1 6,252,136 B1 …

Compositions and methods disclosed herein can help provide improved delivery of non-
natural therapeutic nucleotides for the treatment of diseases such as cancer. An example …

Described herein are unstructured polypeptides lacking any discernible repeat motif. Also
described herein are fusion proteins including at least one of the unstructured polypeptides …

US11649275B2 - Dual agonist fusion proteins - Google Patents US11649275B2 - Dual
agonist fusion proteins - Google Patents Dual agonist fusion proteins Download PDF Info …

A61K31/704—Compounds having saccharide radicals attached to non-saccharide
compounds by glycosidic linkages attached to a carbocyclic compound, eg phloridzin …

Organisms resistant to horizontal gene transfer (HGT), and compositions and methods of
use thereof are provided. The organisms are typically genomically recoded organisms …

Disclosed herein are compositions and methods for reducing the antigenicity of molecules.
The antigenicity of a molecule may be reduced or eliminated by conjugating at least one …